Adult

AWH Commences Adult-Use Sales at Fort Lee Dispensary

Retrieved on: 
Thursday, November 17, 2022
Adult, Perception, Fort Lee lane closure scandal, Ozone, CSE, Cannabis, News, Montclair, Fort Lee, AWH, Multimedia, Annual report, Rochelle Park–Rochelle Heights Historic District, Patient, George Washington Bridge, Tripwire (company), The Company, Rochelle Park, Risk management

Strategically situated near New York City in a densely populated area of northern New Jersey, Ascend Fort Lee is the Company's flagship location in the state.

Key Points: 
  • Strategically situated near New York City in a densely populated area of northern New Jersey, Ascend Fort Lee is the Company's flagship location in the state.
  • Ascend Fort Lee is the Company's third dispensary to open for adult-use sales in New Jersey following the Rochelle Park and Montclair locations earlier this year.
  • Ascend Fort Lee will open for adult use on an appointment-only basis, which can be made at letsascend.com.
  • "We are thrilled to open our doors to a wider audience as we commence adult-use sales at Ascend Fort Lee," said Frank Perullo, interim co-CEO, president, and co-founder of Ascend Wellness Holdings.

Survey: 3 in 10 Students Lose Significant Academic Credits Transferring Between Colleges

Retrieved on: 
Thursday, November 17, 2022
Transfer, University Professional and Continuing Education Association, Adult, University, Aspen, Benchmarking, UPCEA, Student, American Council on Education, Research, Education, StraighterLine, National Student Clearinghouse, COVID-19, Publication, Communication, Public policy, American Council, Tutoring, Medicine

WASHINGTON, Nov. 17, 2022 /PRNewswire/ -- UPCEA (University Professional and Continuing Education Association), the largest association of adult and continuing education units at colleges and universities, and StraighterLine released the findings from a new survey today examining students' lived experiences and perceptions around transferring college credits. As universities and colleges struggle with declining enrollment, many are looking at ways to reach the more than 39 million Americans with some college credit but no degree. The survey of nearly 1,000 adults found learners who transfer want an easier process, better communication and a clearer path to completing their degree. 

Key Points: 
  • National Student Clearinghouse reported in September a two-year decline of 13.5% in the number of transfer learners.
  • Students as Savvy Shoppers.Half (50%) of the students surveyed said they attempted to shop or explore multiple colleges or universities to see which would accept their credits.
  • Leaving Transfer Credits on the Table.At a time when most adult learners are banking on transfer credits to accelerate their time to completion, only 61% of respondents had 75%+ of their credits accepted.
  • Based in Washington, D.C., UPCEA builds greater awareness of the vital link between adult learners and non-traditional learners and public policy issues.

Tarena to Report Third Quarter 2022 Financial Results on November 29, 2022

Retrieved on: 
Thursday, November 17, 2022
Adult, Growth, Conference, Technology, Ageing, Student, Conference call, ID, Education, Ostrinotes tarena, RSVP, NASDAQ, Robotics, Internet service provider, Medicine, STEAM

BEIJING, Nov. 17, 2022 /PRNewswire/ -- Tarena International, Inc. (NASDAQ: TEDU)("Tarena" or the "Company"), a leading provider of IT professional education and IT-focused supplementary STEAM education services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2022, after the U.S. market closes on November 29, 2022.

Key Points: 
  • BEIJING, Nov. 17, 2022 /PRNewswire/ -- Tarena International, Inc. (NASDAQ: TEDU)("Tarena" or the "Company"), a leading provider of IT professional education and IT-focused supplementary STEAM education services in China, today announced that it will report its unaudited financial results for the third quarter ended September 30, 2022, after the U.S. market closes on November 29, 2022.
  • Tarena's management will host an earnings conference call and live webcast at 8:00 a.m. on November 30, 2022, U.S. Eastern Time (9:00 p.m. on November 30, 2022, Beijing Time).
  • Participants can join the conference using the below options:
    Dialing-in to the conference call:
    Please register in advance of the conference, using the link provided below.
  • It will automatically direct you to the registration page of "Tarena's Third Quarter 2022 Earnings Conference Call " where you may fill in your details for RSVP.

SF-Made Complete Case for Steam Deck Equips Users for Ultimate Gaming and mini-PC Experience

Retrieved on: 
Thursday, November 17, 2022
Adult, SAN, Waterfield, Technology, Video, Tablet, Collection, YKK, Nintendo Switch, Steam, Dimension, HDMI, Analogue Pocket, Our Story, Nintendo Switch Lite, Payment card, Tunnel, Video game console, Bookbinding, Cassette tape

SAN FRANCISCO, Nov. 17, 2022 /PRNewswire-PRWeb/ -- WaterField Designs, an innovative San-Francisco maker of bags and cases for digital gear, announces the Complete Case for Steam Deck to organize and protect the Valve Steam Deck and accessories all in one place. Now users can get the most out of the powerful device wherever they go — whether playing video games or setting the handheld up as a miniature personal computer. The ballistic nylon and full-grain leather, all-in-one Steam Deck bag includes a custom-sized plush pocket for every tool a true Steam Deck enthusiast needs: the console, dock, controller, power cords, and even a mechanical keyboard and mouse.

Key Points: 
  • "When we surveyed over 1,500 community members about their ideal Valve Steam Deck case, many requested an adult-looking Steam Deck travel bag that fits their entire set up," said company owner Gary Waterfield.
  • "We researched the most popular Steam Deck docks and accessories and made sure the Complete Case accommodates them all."
  • Dedicated padded pockets cradle the Steam Deck console, Steam Deck or third-party dock, two power supplies, controller, 75% keyboard, and a mouse.
  • The Complete Case for the Steam Deck joins WaterField's Steam Deck CitySlicker case, Pouch for the Steam Deck, and the company's gaming collection of Nintendo Switch cases , Switch Lite cases, and Analogue Pocket cases .

Ardelyx Announces FDA Advisory Committee Votes that the Benefits of XPHOZAH® (tenapanor) Outweigh its Risks for the Control of Serum Phosphorus in Adult Patients with Chronic Kidney Disease on Dialysis

Retrieved on: 
Wednesday, November 16, 2022
OND, Kyowa Hakko Kirin, Indiana University School of Medicine, Adult, Human, Hyperphosphatemia, Conference, NHE3, U.S. Securities and Exchange Commission, Security (finance), Knight Therapeutics, Diarrhea, PAI, Fosun Pharma, Chronic kidney disease, CKD, Hyperkalemia, Metabolic acidosis, Nephrology, Physician, Conference call, Safety, Center for Drug Evaluation and Research, Research, Phosphorus, FDA, ID, View, Center, Therapy, Advisory Committee, Multimedia, Hypertension, Regulation of tobacco by the U.S. Food and Drug Administration, Patient, Blood, Kidney, BID, Dialysis, Food, Endpoint security, Pharmaceutical industry, Facebook

WALTHAM, Mass., Nov. 16, 2022 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs, today announced the vote of the U.S. Food and Drug Administration's (FDA) Cardiovascular and Renal Drugs Advisory Committee (CRDAC) meeting for XPHOZAH for the control of serum phosphorus in adult patients with chronic kidney disease (CKD) on dialysis. The CRDAC voted nine to four that the benefits of treatment with XPHOZAH outweigh its risks for the control of serum phosphorus in adults with CKD on dialysis when administered as a monotherapy and voted ten to two, with one abstention, that the benefits of treatment with XPHOZAH in combination with phosphate binder treatment outweigh its risks.

Key Points: 
  • "We are confident that the data from three Phase 3 clinical trials involving more than 1,200 patients support the approval of XPHOZAH in the U.S. for the control of serum phosphorus in adult patients with CKD on dialysis.
  • We want to thank the patients, physicians and the advocacy community who shared their valuable insights today and throughout the development program.
  • The nephrology community is enthusiastic to have access to this therapy with its novel mechanism of action to help our patients."
  • Ardelyx is developing XPHOZAH (tenapanor), a novel product candidate to control serum phosphorus in adult patients with CKD on dialysis, which has completed three successful Phase 3 trials.

SK Biopharmaceuticals Named CES 2023 Innovation Awards Honoree

Retrieved on: 
Wednesday, November 16, 2022
Zero, Ignis, Somnolence, Technology, Heart, Seizure, CTA, Restless, Weakness, Therapy, Skin, Infection, Central nervous system, Mouth, CNS, Insomnia, Anxiety, Fatigue, Face, ASM, Rash, Greater, FDA, History, Behavior, Depression, Patient, CV, Walking, Engineering, Ideation, Epilepsy, Dizziness, GABAA, Irritability, Blood, Safety, SK, Pregnancy, Mania, Multimedia, Bruise, Vitamin, Central nervous system disease, Consumer Technology Association, CES, Adult, Allergy, Status epilepticus, Tongue, Suicide, Medication, Liver, Union, ASMS, Ono Pharmaceutical, Research, Endo, Nervous system, Thought, Palpitations, Headache, Fever, Bleeding, Smartglasses, Food, Pharmaceutical industry, Liquor, Birth control

PANGYO, South Korea, Nov. 16, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has been named a CES® 2023 Innovation Awards Honoree for outstanding design and engineering of two wearable devices – Zero GlassesTM and Zero WiredTM.

Key Points: 
  • PANGYO, South Korea, Nov. 16, 2022 /PRNewswire/ -- SK Biopharmaceuticals, an innovative global pharmaceutical company, announced that it has been named a CES 2023 Innovation Awards Honoree for outstanding design and engineering of two wearable devices Zero GlassesTMand Zero WiredTM.
  • They are compatible with SK Biopharmaceuticals' mobile application named Zero AppTMthat can record and analyze bio-signal data in real time.
  • SK Biopharmaceuticals operates in the U.S. through SK Life Science, a subsidiary based in New Jersey.
  • SK Biopharmaceuticals will showcase the wearable devices and provide an on-site demonstration at CES 2023.

Goodness Growth Holdings Extends Expungement Efforts with Three Free Clinics

Retrieved on: 
Wednesday, November 16, 2022
Adult, Person, Partnership, Equity, New Mexico Department of Health, CSE, MD, Cannabis, Diversity, Public security, Growth, Record, BIPOC, Volunteering, University of New Mexico School of Law, University, Breach of contract, IP, Industry, Company, Plant, New Mexico Department of Public Safety, Mitchell Hamline School of Law, LPP, Public defender, Justice, Science, Commerce, Pharmaceutical industry, Drug, Medicine, Produce, Law, Color

MINNEAPOLIS, Nov. 16, 2022 /PRNewswire/ -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced that it has continued its efforts to help individuals impacted by non-violent cannabis convictions with three free expungement clinics.

Key Points: 
  • Company-sponsored expungement clinics hosted in Maryland, Minnesota and New Mexico
    MINNEAPOLIS, Nov. 16, 2022 /PRNewswire/ -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the "Company") (CSE: GDNS; OTCQX: GDNSF), a physician-led, science-focused cannabis company and IP developer, today announced that it has continued its efforts to help individuals impacted by non-violent cannabis convictions with three free expungement clinics.
  • During the month of October, Goodness Growth led two expungement clinics in Maryland and New Mexico.
  • Thanks to a partnership with Maryland Legal Aid, Goodness Growth plans to host additional virtual clinics on a quarterly basis.
  • In addition to holding expungement clinics throughout the country, Goodness Growth partners with the Last Prisoner Project ("LPP") in support of its Roll It Up for Justice campaign.

Mark Anthony Thomas Releases Performance Film "Folded Whispers"

Retrieved on: 
Wednesday, November 16, 2022
Adult, University, Taco Shop Poets, Poverty, Child abuse, Getty Images, Kelly-Strayhorn Theater, Civil and political rights, An Eton Poetry Book, Economic development, Poetry Foundation, Poetry, Financial Times and McKinsey Business Book of the Year Award, Book, Love, National, Domestic violence, National Poetry Foundation, Film

PITTSBURGH, Nov. 16, 2022 /PRNewswire-PRWeb/ -- Mark Anthony Thomas, renowned poet and writer turned economic development official, will release the short film "Folded Whispers" revisiting his creative past on streaming platforms on Friday, November 18, 2022.

Key Points: 
  • Mark Anthony Thomas, renowned poet and writer turned economic development official, will release the short film "Folded Whispers" revisiting his creative past on streaming platforms on Friday, November 18, 2022.
  • PITTSBURGH, Nov. 16, 2022 /PRNewswire-PRWeb/ -- Mark Anthony Thomas, renowned poet and writer turned economic development official, will release the short film "Folded Whispers" revisiting his creative past on streaming platforms on Friday, November 18, 2022.
  • The event features Thomas being recorded and performing in front of an intimate crowd at the historic Kelly Strayhorn Theater .
  • Mark Anthony Thomas has produced commissioned works for elected officials, business leaders, and many causes, including domestic violence, civil rights, child abuse, poverty, and global peace.

Patent Awarded for Saliva-Based Test to Help Diagnose Concussion and Predict Duration of Symptoms

Retrieved on: 
Wednesday, November 16, 2022
Hicks, SUNY, Penn State College of Information Sciences and Technology, Technology, Goal, Concussion, Student, Research, Economic development, National Institutes of Health, Commonwealth, Therapy, Technology transfer, Artificial intelligence, State University of New York Upstate Medical University, Saliva, National, Founder, Quadrant, IRC, RNA, Invention, Pennsylvania State University, Motivation, Penn State University College of Medicine, FDA, Athlete, RF, CEO, Intellectual property, Doctor of Philosophy, MD, Hockey, CNN, Environmental Health (journal), Addiction, State university system, Resilience, Multimedia, Risk, Internal Revenue Code, Adult, Education, Patent, State University of New York, Head Injuries, Pharmaceutical industry, Longevity, Biotechnology

SYRACUSE, N.Y., Nov. 16, 2022 /PRNewswire/ -- Quadrant Biosciences announced today that the U.S. Patent and Trademark Office (USPTO) has awarded the company and two of its academic partners, the State University of New York Research Foundation and the Penn State Research Foundation, with U.S. Patent No.11,453,914 for the analysis and prediction of mild traumatic brain injury (mTBI) and concussion symptoms. This research was first mentioned on CNN back in 2017. This patent is a transformative piece of intellectual property that Quadrant is using to develop its Clarifi™ mTBI Saliva Test, expected to be available in late 2023. Quadrant has started discussions about potentially licensing this technology to third-parties. This test uses small non-coding RNAs found in the saliva to help diagnose concussions.

Key Points: 
  • This patent is a transformative piece of intellectual property that Quadrant is using to develop its Clarifi mTBI Saliva Test, expected to be available in late 2023.
  • This test uses small non-coding RNAs found in the saliva to help diagnose concussions.
  • That's when I discovered there needed to be a better, more exact way to diagnose concussions.
  • This is the second patent awarded in less than one year to Quadrant and its partners.

Adventist HealthCare Fort Washington Medical Center Receives Improved Hospital Safety Grade Indicating Commitment to Excellence.

Retrieved on: 
Wednesday, November 16, 2022
Health, Accident, Injury, Adult, Adventism, Hospital Insurance and Diagnostic Services Act, Patient safety organization, Cardiology, Adventist HealthCare, Rehabilitation, Radiology, Pharmacy, Safety, University of Maryland Baltimore Washington Medical Center, Patient, Person-centered therapy, Infection, Hospital, Patient safety, Medicine

FORT WASHINGTON, Md., Nov. 16, 2022 /PRNewswire/ -- The Leapfrog Group, a national watchdog organization that uses its influence to foster positive change in health care has awarded Adventist HealthCare Fort Washington Medical Center a "B" Hospital Safety Grade rating, making it one of the safest hospitals in Maryland.

Key Points: 
  • FORT WASHINGTON, Md., Nov. 16, 2022 /PRNewswire/ -- The Leapfrog Group, a national watchdog organization that uses its influence to foster positive change in health care has awarded Adventist HealthCare Fort Washington Medical Center a "B" Hospital Safety Grade rating, making it one of the safest hospitals in Maryland.
  • Fort Washington Medical Center joined the Adventist HealthCare system in 2019 and has since made tremendous strides to improve its delivery of care.
  • "I am immensely proud of our team that has worked incredibly hard over the past few years to achieve this milestone," said Eunmee Shim, president of Adventist HealthCare Fort Washington Medical Center.
  • Part of the Adventist HealthCare system, and recognized for excellence in patient safety, Fort Washington Medical Center is a 50-bed acute care hospital in Prince George's County, Maryland.